Skip to content

Assessing the clinical severity and treating peri-implantitis surrounding dental implants in patients who recovered from COVID-19

A clinical evaluation of severity and management of peri-implantitis around dental implant in post COVID 19 patients- Randomized control trial - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065969
Enrollment
60
Registered
2024-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T857- Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts

Interventions

Intervention1: Mechanical debridement with adjunct laser therapy: Following mechanical debridement with the help of a sterile ultrasonic scaler and titanium curettes. After proper irrigation with the

Sponsors

Council of Science and Technology U P
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Post covid-19 healthy subjects will be recruited who have SPO2, Pulse rate, Blood pressure within standard limits. Ability to understand the procedure and provide informed consent assessed by decision making capacity and approaches before being included in the study. Diagnosis of peri-implantitis based on the soft tissue around the implant showing obvious inflammatory symptoms, bone loss revealed by X-ray examination and probable haemorrhage and suppuration. At least 2 implant site with periodontal PD �4- 6 mm. Plaque Index around the implant � 2 points Visible bleeding around the implant after probing. CAL � 3 mm.

Exclusion criteria

Exclusion criteria: Current smoking habit with moderate or heavy smoking (more than 10 cigarettes per day) or chewing tobacco. History of drug abuse or alcoholism within the past 5 years Severe bruxism or clenching habit. Significant untreated periodontal disease (grade III or IV), caries, or clinical or radiographic signs of infection within two adjacent tooth positions of implant area. History of systemic disease that precludes standard dental implant therapy. Past history of implant repair and failure over past 6 months.

Design outcomes

Primary

MeasureTime frame
1. Clinical evaluation of Peri-implant plaque index (PI), BOP, PPD, CAL. 2. Radiographically evaluation of Marginal bone loss. 3. Evaluation of OPG levels in Peri-implant sulcular fluid (PISF).Timepoint: Upto 2 years

Secondary

MeasureTime frame
1. Evaluation of implant stability by Resonance frequency test. 2. Evaluation of pink and white aesthetic score.Timepoint: Upto 2 years

Countries

India

Contacts

Public ContactMayank Singh

King Georges Medical University

lakshya79@yahoo.com9412119778

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 27, 2026